Clinical Trials · NCT00931372

Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2

Name: Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 1Lixisenatide

Phase: Phase 1
Recruitment status: Completed
Sponsor: Sanofi
Enrollment: 22
Start date: Jun 2009
Locations: 1 site, Germany
Primary endpoint: Area under the insulin secretion curve

View Lixisenatide compound reference